The World's Greatest Investing Community
Results 51 - 60 of 545 : Previous 2 3 4 5 6 7 8 9 10 Next
Dendreon 2011: Supply Constrained to Missed Guidance
A year in review for the biotech.
What These Top ETF Picks Predict for 2012
ETF trends can tell you a lot about investing generally.
BioSante Investors: It Was Nice While It Lasted
Libigel loses to placebo in two studies, shares down 75% after hours.
3 Biotechs Making Big Moves on Big News
Trial results and FDA panels ruled the health-care sector today.
These stocks just rolled over. Can they come back?
A medical transformation is coming.
1 Biotech Soars While Another Crashes
Cell Therapeutics dilutes shareholders while SIGA squashes fears.
A Soaring Biotech With Room to Run
Affymax gets a leg up from an FDA advisory panel vote.
Our investing community's latest prime pick to avoid -- Peregrine Pharmaceuticals.
The Best ETF for 2012: SPDR S&P Biotech
Why choose one or two promising stocks when you can buy a big bunch?
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK